ArticleFrontiers in medicine2022

Safety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial.

Nidal Muvarak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.